<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication" xmlns:n2016="http://publications.europa.eu/resource/schema/ted/2016/nuts" xsi:schemaLocation="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication TED_EXPORT.xsd" VERSION="R2.0.9.S03.E01" DOC_ID="577407-2020" EDITION="2020234"><TECHNICAL_SECTION><RECEPTION_ID>20-598263-001</RECEPTION_ID><DELETION_DATE>20210306</DELETION_DATE><FORM_LG_LIST>FR </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>234</NO_OJ><DATE_PUB>20201201</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2020/S 234-577407</NO_DOC_OJS><URI_LIST><URI_DOC LG="FR">http://ted.europa.eu/udl?uri=TED:NOTICE:577407-2020:TEXT:FR:HTML</URI_DOC></URI_LIST><LG_ORIG>FR</LG_ORIG><ISO_COUNTRY VALUE="BE"/><IA_URL_GENERAL>www.chu-charleroi.be</IA_URL_GENERAL><ORIGINAL_CPV CODE="33690000">Various medicinal products</ORIGINAL_CPV><ORIGINAL_CPV CODE="33673000">Medicinal products for obstructive airway diseases</ORIGINAL_CPV><n2016:PERFORMANCE_NUTS CODE="BE322">Arr. Charleroi</n2016:PERFORMANCE_NUTS><n2016:CA_CE_NUTS CODE="BE322">Arr. Charleroi</n2016:CA_CE_NUTS><n2016:TENDERER_NUTS CODE="BE">BELGIQUE-BELGIË</n2016:TENDERER_NUTS><VALUES><VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">640345.71</VALUE></VALUES><REF_NOTICE><NO_DOC_OJS>2020/S 140-344273</NO_DOC_OJS></REF_NOTICE></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20201126</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="8">Other</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="1">Open procedure</PR_PROC><RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01B03</HEADING><INITIATOR>01</INITIATOR></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Бeлгия</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Разни медикаменти</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Belgie</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Různé léčivé přípravky</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Belgien</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Diverse lægemidler</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Belgien</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Varia</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Βέλγιο</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Διάφορα φάρμακα</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Belgium</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Various medicinal products</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>Bélgica</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Medicamentos diversos</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Belgia</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Mitmesugused ravimid</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Belgia</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Muut lääkkeet</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Belgique</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Médicaments divers</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Bheilg, an</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Various medicinal products</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Belgija</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Razni lijekovi</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Belgium</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Különböző gyógyszerek</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Belgio</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Medicinali vari</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Belgija</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Kiti vaistai</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Beļģija</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Dažādas zāles</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>il-Belġju</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Prodotti mediċinali varji</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>België</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Diverse geneesmiddelen</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Belgia</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Różne produkty lecznicze</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Bélgica</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Medicamentos vários</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Belgia</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Diverse medicamente</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Belgicko</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Rôzne liečivá</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Belgija</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Različna zdravila</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Belgien</TI_CY><TI_TOWN>Charleroi</TI_TOWN><TI_TEXT><P>Varia</P></TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="FR">Intercommunale de santé publique du Pays de Charleroi SCRL</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="FR"><LEGAL_BASIS VALUE="32014L0024"/><CONTRACTING_BODY><ADDRESS_CONTRACTING_BODY><OFFICIALNAME>Intercommunale de santé publique du Pays de Charleroi SCRL</OFFICIALNAME><NATIONALID>ISPPC</NATIONALID><ADDRESS>Boulevard Zoé Drion 1</ADDRESS><TOWN>Charleroi</TOWN><POSTAL_CODE>6000</POSTAL_CODE><COUNTRY VALUE="BE"/><PHONE>+32 71920121</PHONE><E_MAIL>avisdemarche@chu-charleroi.be</E_MAIL><n2016:NUTS CODE="BE322"/><URL_GENERAL>www.chu-charleroi.be</URL_GENERAL></ADDRESS_CONTRACTING_BODY><CA_TYPE_OTHER>Intercommunale</CA_TYPE_OTHER><CA_ACTIVITY VALUE="HEALTH"/></CONTRACTING_BODY><OBJECT_CONTRACT><TITLE><P>Fourniture de Déférasirox et Omalizumab 2020-2024</P></TITLE><REFERENCE_NUMBER>2020-0881</REFERENCE_NUMBER><CPV_MAIN><CPV_CODE CODE="33690000"/></CPV_MAIN><TYPE_CONTRACT CTYPE="SUPPLIES"/><SHORT_DESCR><P>Ce marché a pour objet:</P><P>1) la fourniture de Déférasirox, une molécule pour le traitement de la surcharge martiale en fer secondaire à des transfusions sanguines fréquentes lorsque le traitement par la Déféroxamine est contre-indiqué ou inadapté:</P><P>— la bèta-thalassémie majeure;</P><P>— la drépanocytose homozygote;</P><P>— une défaillance congénitale de la moelle osseuse;</P><P>— le syndrome de la myélodysplasie pour lequel un patient présente un score IIPSS (au maximum 1,5 point);</P><P>2) la fourniture d'Omalizumab, un anticorps monoclonal humanisé biosynthétique anti-IgE pour le traitement de l'asthme chez les patients présentant une dépendance aux IgE ou un urticaire chronique.</P></SHORT_DESCR><VAL_TOTAL CURRENCY="EUR">640345.71</VAL_TOTAL><LOT_DIVISION/><OBJECT_DESCR ITEM="1"><TITLE><P>Déférasirox</P></TITLE><LOT_NO>1</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33690000"/></CPV_ADDITIONAL><n2016:NUTS CODE="BE322"/><MAIN_SITE><P>ISPPC SCRL — CHU de Charleroi — site A. Vésale, rue de Gozée 706 à 6110 Montigny-le-Tilleul/ISPPC SCRL — CHU de Charleroi — site Hôpital civil marie Curie, Chée d...(voir documents du marché).</P></MAIN_SITE><SHORT_DESCR><P>Fourniture de Déferasirox 360 mg.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="2"><TITLE><P>OMALIZUMAB</P></TITLE><LOT_NO>2</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33690000"/></CPV_ADDITIONAL><CPV_ADDITIONAL><CPV_CODE CODE="33673000"/></CPV_ADDITIONAL><n2016:NUTS CODE="BE322"/><MAIN_SITE><P>ISPPC SCRL — CHU de Charleroi — site A. Vésale, rue de Gozée 706 à 6110 Montigny-le-Tilleul/ISPPC SCRL — CHU de Charleroi — site Hôpital civil marie Curie, Chée d...(voir documents du marché).</P></MAIN_SITE><SHORT_DESCR><P>Fourniture d'Omalizumab 75 et 150 mg.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR></OBJECT_CONTRACT><PROCEDURE><PT_OPEN/><FRAMEWORK/><CONTRACT_COVERED_GPA/><NOTICE_NUMBER_OJ>2020/S 140-344273</NOTICE_NUMBER_OJ></PROCEDURE><AWARD_CONTRACT ITEM="1"><CONTRACT_NO>2020-0881</CONTRACT_NO><LOT_NO>1</LOT_NO><TITLE><P>Déférasirox</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-11-24</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_SME>0</NB_TENDERS_RECEIVED_SME><NB_TENDERS_RECEIVED_EMEANS>1</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Novartis Pharma</OFFICIALNAME><ADDRESS>Medialaan 40/1</ADDRESS><TOWN>Vilvoorde</TOWN><POSTAL_CODE>1800</POSTAL_CODE><COUNTRY VALUE="BE"/><PHONE>+32 22461611</PHONE><E_MAIL>hospital.belgium@novartis.com</E_MAIL><FAX>+32 22461737</FAX><n2016:NUTS CODE="BE"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">119948.19</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="2"><CONTRACT_NO>2020-0881</CONTRACT_NO><LOT_NO>2</LOT_NO><TITLE><P>Omalizumab</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-11-24</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_SME>0</NB_TENDERS_RECEIVED_SME><NB_TENDERS_RECEIVED_EMEANS>1</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Novartis Pharma</OFFICIALNAME><ADDRESS>Medialaan 40/1</ADDRESS><TOWN>Vilvoorde</TOWN><POSTAL_CODE>1800</POSTAL_CODE><COUNTRY VALUE="BE"/><PHONE>+32 22461611</PHONE><E_MAIL>hospital.belgium@novartis.com</E_MAIL><FAX>+32 22461737</FAX><n2016:NUTS CODE="BE"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">520397.52</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><COMPLEMENTARY_INFO><ADDRESS_REVIEW_BODY><OFFICIALNAME>Conseil d’État – section administration</OFFICIALNAME><ADDRESS>Rue de la Science 33</ADDRESS><TOWN>Bruxelles</TOWN><POSTAL_CODE>1040</POSTAL_CODE><COUNTRY VALUE="BE"/></ADDRESS_REVIEW_BODY><REVIEW_PROCEDURE><P>Recours en référé devant un juge judiciaire ou en extrême urgence devant le conseil d'état: quinze jours à dater du lendemain de la notification (incluant les motivations).</P><P>Recours en annulation au Conseil d'État selon la procédure de droit commun: 60 jours à dater du lendemain de la notification (incluant les motivations).</P></REVIEW_PROCEDURE><DATE_DISPATCH_NOTICE>2020-11-26</DATE_DISPATCH_NOTICE></COMPLEMENTARY_INFO></F03_2014></FORM_SECTION></TED_EXPORT>